Related Experiment Video
Updated: Aug 19, 2026

Measuring Volatile and Non-volatile Antifungal Activity of Biocontrol Products
Published on: December 5, 2020
Antimicrobial activity of Streptomyces species against mushroom blotch disease pathogen
1Mugla University, Egitim Fakultesi, Biyoloji Egitimi Anabilim Dali, TR-48170 Kotekli, Mugla, Turkey. nsahin@mu.edu.tr
Abstract:
Bacterial blotch caused by Pseudomonas tolaasii is still one of the main diseases in mushroom farms. Effective treatment of the infections caused by P. tolaasii is yet to be established. The isolation and identification of three Streptomyces species that showed antimicrobial activity against P. tolaasii NCPPB 2192(T) were described. Six strains were highly active with an inhibition zone more than 20 mm in diameter. They were assigned to the known Streptomyces cluster groups as S. rochei, S. lydicus and S. antibioticus. The fermentation, preliminary extraction and isolation of bioactive components were carried out. The bioactive compound may be a beta-lactam structurally related to the penicillins.
Insights
Researchers identified three Streptomyces species with potent antimicrobial activity against Pseudomonas tolaasii, a common mushroom farm pathogen. These findings offer potential new treatments for bacterial blotch disease.
Area of Science:
- Microbiology
- Mycology
- Agricultural Science
Background:
- Bacterial blotch, caused by Pseudomonas tolaasii, is a significant disease affecting mushroom cultivation.
- Current treatments for Pseudomonas tolaasii infections are insufficient, necessitating novel therapeutic strategies.
Purpose of the Study:
- To isolate and identify microorganisms exhibiting antimicrobial activity against Pseudomonas tolaasii.
- To characterize the bioactive compounds produced by these microorganisms.
Main Methods:
- Isolation and identification of Streptomyces species from environmental samples.
- Antimicrobial susceptibility testing against Pseudomonas tolaasii NCPPB 2192(T).
- Fermentation, extraction, and preliminary purification of bioactive compounds.
Main Results:
- Three Streptomyces species (S. rochei, S. lydicus, S. antibioticus) demonstrated significant antimicrobial activity.
- Six strains exhibited high efficacy, with inhibition zones exceeding 20 mm.
- A bioactive compound, potentially a beta-lactam related to penicillin, was isolated.
Conclusions:
- Streptomyces species are a promising source for novel antimicrobial agents against Pseudomonas tolaasii.
- The identified bioactive compound warrants further investigation for its therapeutic potential in controlling bacterial blotch in mushroom farms.
Related Concept Videos
Antifungal Agents
Antimicrobial Effectiveness
Bacterial Phylum Actinobacteria
Microbe-Plant Interactions
Fungal Group Zygomycota
Clinical Significance of Antibiotic Resistance

